Advertisement

Topics

Companies Related to "NeoSync Secures Million Financing With Valiance Life Science" [Most Relevant Company Matches] RSS

04:31 EST 24th November 2017 | BioPortfolio

Here are the most relevant search results for "NeoSync Secures Million Financing With Valiance Life Science" found in our extensive corporate database of over 50,000 company records.

Showing "NeoSync Secures Million Financing With Valiance Life Science" Companies 1–25 of 6,900+

Relevant

Phagenesis Ltd

Phagenesis is developing the first clinically proven treatment for dysphagia, a debilitating and often lethal condition in which the patient’s ability to swallow is damaged. Dysphagia can lead to the inhalation of solids or liquids followed by pneumonia. Sufferers face being fed through a tube indefinitely, reduced life expectancy and quality of life....


Synchroneuron Inc.

Synchroneuron Inc. is a privately held life science company based in the Boston area engaged in developing novel treatments to treat tardive dyskinesia (TD) and other neuropsychiatric disorders . Synchroneuron Inc. was founded in 2011 by inventor and neurologist Barry Fogel, MD, and the principals (William Kerns, DVM, Kei-Lai Fong, PhD, and Marc Cote) of A...

Partners for Development investments in Life Sciences, P.U.L.S. AB

Partners for Development investments in Life Sciences, P.U.L.S. AB (PULS) was founded in 2002. PULS acts as an incubator and investor for early projects within life science, mostly drug development, and has started nine project companies. PULS consist of an operational management team and more than 30 partners with long experience in life sciences and competence through the whole value chain, ...


BioRegioN GmbH

BioRegioN GmbH is the successor to the BioRegioN initiative, and is the central point of contact for life science of the state of Lower Saxony. It provides specialist consultation on the life science sector to new enterprises and start-ups. BioRegioN GmbH provides entrepreneurs with support during company set-up, and in financing, marketing and sales.

BioAgency AG

combines financial, consulting and broker services to support the life science industry. aids researchers in developing, financing, protecting and marketing their intellectual property, provides biotech startups with early stage capital and management support and acts as a product candidate and technology broker. serves investors, attorneys and other service providers as a counselor in life scienc...

Oxford Bioscience Partners

Oxford Bioscience Partners (OBP) is a life science venture capital firm that provides equity financing and management assistance to advanced-stage start-ups and later-stage commercially oriented organizations. The General Partners of OBP currently manage venture funds with committed capital of more than $800 million.

MVM Life Science Partners LLP

MVM creates, finances and builds life science companies that develop world-class technology with a clear focus on products for major markets. MVM manages the UK Medical Ventures Fund and the MVM International Life Sciences Fund. The funds enjoy a close relationship with and rights to technology owned by the Medical Research Council.Our investment team has extensive experience in starting, financin...

GQ Life Sciences, Inc.

GQ Life Sciences, Inc. is a global life science information and search company. Leveraging deep expertise in biology, genomics, and semantics, GQ Life Sciences produces GenomeQuest, including its GQ-Pat collection of over 300 million biological sequences found in the patent domain, and LifeQuest, its vertical search application in the life science intellec...

Abingworth Management Ltd

Abingworth is a vital player among life science venture capital investors on both sides of the Atlantic, with offices in London and Palo Alto. Abingworth has funds under management of over $300 million, 8 experienced professionals and backed more than 60 life science firms, most of which have gone public or been acquired. Abingworth is a strongly science-driven organization and has the resources a...

MediGen Group LLC

Founded in 2001, MediGen Group is a private equity firm that provides venture financing and management assistance to start-up and early-stage companies in the biotechnology and medical device industries.Our objective is to assist the world class Texas based life science organizations and their researchers / inventors with access to commercial skills that will allow them to fully realize the potent...

Oxford Finance Corporation

Oxford Finance Corporation is a specialty financial services firm headquartered in historic Alexandria, Virginia, with offices in Massachusetts and southern and northern California. For almost two decades, our management team has provided loans to pioneers in the life science industry, and today we are the only financial institution dedicated exclusively to this field.Oxford has originated over $5...

ChinaBio® LLC

Since its founding in January, 2007, ChinaBio® LLC has rapidly created a broad platform of capabilities connecting China life science with the world. ChinaBio has helped global life science companies identify over 400 licensing and acquisition opportunities in China and China companies raise over $450 million.

Symphogen A/S

Symphogen A/S, the biotech company pioneering recombinant human polyclonal antibodies for the treatment and prevention of human disease, today announced the initial closing of a USD 25 million Series D financing at a premium to the last financing round.

norgenta GmbH

"Norgenta North German Life Science Agency is the service provider for the life sciences in Hamburg and Schleswig-Hol_stein. Under the common brand name Life Science Nord it supports, networks and coordinates life science activities in North Germany for an internationally competitive cluster."

BioInnovation LLC

BioInnovation (www.bioinnovation.co) has a unique, impact focused business model for life science innovators. As investors and entrepreneurs ourselves, we understand the needs of early-stage healthcare companies, and the end-to-end requirements needed to start, grow and build successful enterprises. The principals of BioInnovation operate leading lab-based...

H.I.G. BioHealth Partners

H.I.G. BioHealth Partners is the dedicated life-science investment affiliate of H.I.G. Capital. H.I.G. BioHealth Partners invests in a broad range of healthcare opportunities across sectors and stages, principally in companies developing therapeutic drugs, medical devices, and diagnostics for significant unmet medical needs. With approximately $400 million...

Pieris AG

Pieris was established in January 2001 with the vision of commercially exploiting technologies developed originally by Prof. Dr. Arne Skerra, Head of the Department of Biological Chemistry at the Technical University of Munich (TUM), Germany. While the scientific excellence of Prof. Dr. Skerra and his fellow Pieris co-founders has long been recognized by the academic community, the product commerc...

Biocompare, Inc.

Biocompare, Inc. (www.biocompare.com), headquartered in South San Francisco, California, is the leading global media company informing and connecting the buyers, users and sellers of life science products. By combining an in-depth knowledge of life science products and new technologies with the power of the Internet, Biocompare offers the most dynamic, relevant, and innovative media-based marketpl...

Nextech Venture, L.P

Nextech Venture, L.P., founded in 1999, is a U.S. limited partnership withCHF 70 million under management and with an office in Zurich, Switzerland. We are investing in selected life science companies in Europe.We help build up successful business ventures from innovations originating in academia and industry in life science and we also support the incubation process of a strong research team in t...

De Novo Pharmaceuticals

The commercial focus of De Novo is the exploitation of human genomics in drug discovery through in silico drug design. The company attracted £2 million financing in a first VC-backed investment round in April 2000, followed by a second round of funding of £16.75 million in July 2001. Investors in the first round included Avlar Bioventures, Prelude Technology and Cambridge Research and Innovati...

Domantis Inc

Domantis Limited was launched in December 2000 by Sir Gregory Winter and Dr Ian Tomlinson of the MRC–LMB with the backing of the MRC and MVM Limited to commercialise Domain Antibody products. To date, Domantis has raised a total of $83M, most recently attracting additional $29 million in a Series B prime venture financing in December 2005 from new investors Novo Nordisk and MC Life Science Ventu...

Golub Capital

With $4 billion in capital, Golub Capital is a leading provider of financing solutions for the middle market, including one-loan financings (through the firm's proprietary GOLD facility), senior, second lien and subordinated debt, preferred stock and co-investment equity. The firm also underwrites and syndicates senior credit facilities up to $200 million. Golub Capital's hold sizes range from $10...

Skada Capital

Skada Capital (www.skadacapital.com) is a Maryland-based provider of financing solutions to healthcare, government contracting and technology companies in the Mid-Atlantic region. With over 200 sources of capital in its network, Skada Capital tailors solutions for companies seeking cash flow financing or growth capital for expansion. Skada Capital speciali...

Scandinavian Life Science

The Scandinavian Life Science Database is a comprehensive database presenting the power of the Scandinavian Life Science industry. The database has become possible through an unique project merging together a number of regional databases in Sweden, Norway and Denmark. The result is a database containing more than 1 500 companies! Here you may search for companies within the entire Life Science spa...

Life-science-man Oy Ltd

Life-science-man is a private, independent advisory company providing expert services for the life-science and chemical industries. We are specialists in business development including regulatory affairs and clinical trials. Our team provides you with the focused expert services in.


More From BioPortfolio on "NeoSync Secures Million Financing With Valiance Life Science"

Quick Search
Advertisement
 

Corporate Database Quicklinks